Percutaneous coronary intervention (#PCI) guided by optical coherence tomography (#OCT) reduces adverse cardiac events in patients with bifurcation lesions ⬇️ #ESCCongress OCTOBER trial

PhD student Lene N Andreasen presented the OCTOBER Trial showing superiority of using OCT in guiding complex bifurcation PCI and had simultaneous NEJM publication. Great achievent Lene and congratulations to the whole OCTOBER organisation. 👏👏👏 DOI: 10.1056/NEJMoa2307770

OCTOBER Trial: OCT Reduces MACE in complex bifurcation lesions Written by Lucas Marinacci, MD Summary and analysis and more #ESCCongress coverage below! cardiologynownews.org/october-trial-… C. Michael Gibson MD

Don't miss OPCI, in partnership with Optima Education, at #OptimalPCILondon! Explore critical issues facing interventional cardiologists. Register now at bit.ly/3Q6e7obnow for high-quality lectures, live cases, debates and interactive workshops. Allen Jeremias Evan Shlofmitz Ziad Ali

#imagefirst

Awesome work Lewis Aimson 🤙🏼🤙🏼🤙🏼

#Abbottproud to have been a major partner and to have attended #OptimalPCI2023 event in London at the Royal College of Physicians over the last two days. A truly fantastic educational event delivered by Optima Education and expert faculty. #WHYHOWTRY

🖥️ Imaging and PCI: are we ready for a new paradigm shift? 💡 🎯 Let's learn to use OCT before, during and after PCI; standardize the application is the goal 📈 🎯 Let's use intravascular imaging more and learn how to use it better 🥇 #GISE44 #OCT #ILLUMIENIV #OCTOBER #OCTIVUS

ORBITA-COSMIC is set to critically assess the Coronary Sinus Reducer's effectiveness on myocardial perfusion and angina relief through a double-blind, randomized trial, comparing it against a placebo. This study will crucially inform the clinical use of CSR for patients with

#OCT Interesting cases #1 61 yo, CHILD B cirrhosis, HCC, primary sclerotic cholangitis, no known active hematologic issue #anteriorSTEMI mid-dist LAD pPCI #Penumbra #CatRX and Heparin Re-Look 3 days after with #OCT #Ultreon2.0 what is your diagnosis? poll in thread

Join Optima on the 26th of March 2024, for meeting with world-renowned experts and complex PCI operators, focused on calcium modification and bifurcation strategies. Still time to register: vascular.abbott.com/CORE-2024 Abbott Cardiovascular

Amazing day in London as we hosted 100+ delegates for CORE 2024. ❤️4 live cases from across Europe ❤️OCT guided bifurcation and Calcium PCI procedures ❤️Live OCT demo’ during live cases for optimised OCT learning ❤️1.5 hours hands on training for all delegates #abbottproud

Some great education surrounding OCT today in Dublin Dr Peter O'Kane Abbott Cardiovascular Jack Andrews

#P2POCT day in Dublin with top faculty Nilesh Pareek Dr Peter O'Kane . Educating Derry Cardiologists Edwina McNaughton and I on IC OCT imaging. Huge thanks to Abbott Cardiovascular Aine Nugent Lewis Aimson for invitation and slick delivery 🙏🏻

This is the key advantage of MRR 🔑MMR is able to identify microvascular disease even in the presence of epicardial disease 👌🏻What is even better, it’s easy to calculate: MRR = CFR/FFR x (Pa rest/Pa Hyper)

Brian Bergmark presenting data around real world use of microvascular testing in patients undergoing cardiac cath Decision to use coroflow at start of case usually occurring after angio- marked impact on decision making Hany Ragy Dr Asif Qasim MA PhD FRCP MIЯVΛƬ #IC ༄ ｡° Dr. Raed Alkutshan MD, FSCAI رائد القطشان

PPG Global TCTMD #TCT2024 💪 Patients with high PPG (focal disease) experienced less angina at 1 year 🔑 Those with low PPG had more residual angina and showed similar responses to medication, PCI, or surgery PPG is a novel application of coronary physiology PCRonline 🫀

Stent-edge calcium may predispose to the development of calcific nodules and increased cardiac events David J. Cohen, MD, MSc Doosup Shin Allen Jeremias Yoichiro.S@循環器内科医 @EShlof Omar Khalique @DakroubAli_ Ziad Ali #AHAJournals ahajrnls.org/3FaLMtL